A new generation of bioresonance
In 2012, when Martin Keymer, Dr. Walther Medinger and Dr. med. Peter Kreisl discussed the status quo of bioresonance therapy for the first time, they were unaware of the far-reaching significance of their subsequent technical discussions and the resulting positive impulses for bioresonance devices. But the need for newly created solutions became obvious very soon.
With the founding of the company apere GmbH & Co. KG, the entrepreneurial foundation for an innovative operation in the field of bioresonance therapy was laid. An expert team of scientists and specialists from the medical technology industry successfully worked hand in hand on the implementation of the new bioresonance system: the apere-BMS.
And the successful course continued: With the apere resonator, the company launched the next pioneering and trendsetting development stage on the market just one year later. The patented apere resonator is an exemplary reflection of the high scientific standards of the company. This is because apere relies on know-how and professionalism in the technical as well as the business management area. Its team includes excellent specialists, such as senior electricians and employees with commercial skills.
Since the company was founded in 2015, it has grown steadily, so that in addition to the location in Wendtorf near Kiel, a further branch was opened. As a North German company, apere deliberately decided for a branch in Hamburg, which was taken into service in 2017. In its new office in the Hanseatic city, the apere team is constantly working on new developments. That apere is on the right track is proved by the steady growth of the company.